Cancer Research UK increases usage of Lasergene
2 February 2007Tweet
Bioinformatics company DNAStar has expanded its license agreement with Cancer Research UK (CR-UK) to include the Cambridge Research Institute and The Paterson Institute for Cancer Research.
The agreement allows the new locations of CR-UK to use the current version of DNAStar’s Lasergene software for a three-year period.
The Lincoln’s Inn Field and Clare Hall laboratory campuses already use Lasergene, a suite of tools for molecular biologists and geneticists used in the assembly and analysis of DNA and protein sequences.